These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 39227723)
21. Effect of Evolocumab in Patients With Prior Percutaneous Coronary Intervention. Furtado RHM; Fagundes AA; Oyama K; Zelniker TA; Tang M; Kuder JF; Murphy SA; Hamer A; Wang H; Keech AC; Giugliano RP; Sabatine MS; Bergmark BA Circ Cardiovasc Interv; 2022 Mar; 15(3):e011382. PubMed ID: 35209731 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of high-dose rosuvastatin preloading in patients undergoing percutaneous coronary intervention: a meta-analysis of fourteen randomized controlled trials. Pan Y; Tan Y; Li B; Li X Lipids Health Dis; 2015 Aug; 14():97. PubMed ID: 26306625 [TBL] [Abstract][Full Text] [Related]
23. Statins and Incidence of Contrast-Induced Acute Kidney Injury Following Coronary Angiography - Five Year Experience at a Tertiary Care Center. Sreenivasan J; Khan MS; Li H; Zhuo M; Patel A; Fugar S; Tarbutton M; Siddamsetti S; Yadav N Cardiovasc Revasc Med; 2019 Aug; 20(8):654-658. PubMed ID: 30318173 [TBL] [Abstract][Full Text] [Related]
24. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial. Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071 [TBL] [Abstract][Full Text] [Related]
25. Preprocedural statin use in patients undergoing percutaneous coronary intervention. Kenaan M; Seth M; Aronow HD; Naoum J; Wunderly D; Mitchiner J; Moscucci M; Gurm HS; Am Heart J; 2014 Jul; 168(1):110-6.e3. PubMed ID: 24952867 [TBL] [Abstract][Full Text] [Related]
26. Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy. Ndrepepa G; Braun S; Tada T; Guerra E; Schunkert H; Laugwitz KL; Kastrati A Cardiovasc Revasc Med; 2014 Apr; 15(3):131-6. PubMed ID: 24630704 [TBL] [Abstract][Full Text] [Related]
27. Impact of Chronic Statin Therapy on Postprocedural Contrast-Induced Nephropathy in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention. Chanin JM; Yang DC; Haider MA; Swaminathan RV; Kim LK; Charitakis K; Tanoue M; Minutello RM; Gade CL; Singh HS; Bergman G; Wong SC; Feldman DN J Invasive Cardiol; 2015 Nov; 27(11):490-6. PubMed ID: 25999136 [TBL] [Abstract][Full Text] [Related]
28. Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention. Guedeney P; Claessen BE; Baber U; Camaj A; Sorrentino S; Aquino M; Blum M; Chandiramani R; Goel R; Elsayed S; Kovacic JC; Sweeny J; Barman N; Moreno P; Dangas GD; Kini A; Sharma S; Mehran R Am J Cardiol; 2019 Jun; 123(11):1788-1795. PubMed ID: 30955866 [TBL] [Abstract][Full Text] [Related]
29. Impact of Paradoxical Decrease in High-density Lipoprotein Cholesterol Levels After Statin Therapy on Major Adverse Cardiovascular Events in Patients with Stable Angina Pectoris. Hirayama K; Ota T; Harada K; Shibata Y; Tatami Y; Harata S; Kawashima K; Kunimura A; Shimbo Y; Takayama Y; Kawamiya T; Yamamoto D; Osugi N; Suzuki S; Ishii H; Murohara T Clin Ther; 2017 Feb; 39(2):279-287. PubMed ID: 28034517 [TBL] [Abstract][Full Text] [Related]
30. Usefulness of Elevated Levels of Growth Differentiation Factor-15 to Classify Patients With Acute Coronary Syndrome Having Percutaneous Coronary Intervention Who Would Benefit from High-Dose Statin Therapy. Tentzeris I; Farhan S; Freynhofer MK; Rohla M; Jarai R; Vogel B; Baumgartner-Parzer S; Nürnberg M; Geppert A; Wessely E; Wojta J; Huber K; Kautzky-Willer A Am J Cardiol; 2017 Sep; 120(5):747-752. PubMed ID: 28734463 [TBL] [Abstract][Full Text] [Related]
31. High-Intensity Versus Non-High-Intensity Statins in Patients Achieving Low-Density Lipoprotein Cholesterol Goal After Percutaneous Coronary Intervention. Kim J; Park KT; Jang MJ; Park TK; Lee JM; Yang JH; Song YB; Choi SH; Gwon HC; Lee SH; Hong KP; Hahn JY J Am Heart Assoc; 2018 Nov; 7(21):e009517. PubMed ID: 30376751 [TBL] [Abstract][Full Text] [Related]
32. Impact of platelet turnover on long-term adverse cardiovascular outcomes in patients undergoing percutaneous coronary intervention. Tscharre M; Farhan S; Bruno V; Rohla M; Egger F; Weiss TW; Hübl W; Willheim M; Wojta J; Geppert A; Huber K; Freynhofer MK Eur J Clin Invest; 2019 Sep; 49(9):e13157. PubMed ID: 31318979 [TBL] [Abstract][Full Text] [Related]
33. High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in East Asian patients undergoing percutaneous coronary intervention: A meta-analysis of fifteen randomized controlled trials. Liu J; Zhang B; Chen M; Zheng B Medicine (Baltimore); 2021 Jun; 100(25):e26278. PubMed ID: 34160392 [TBL] [Abstract][Full Text] [Related]
34. Prognostic value of total bilirubin in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention. Gul M; Uyarel H; Ergelen M; Akgul O; Karaca G; Turen S; Ugur M; Ertürk M; Kul S; Surgit O; Bozbay M; Uslu N Am J Cardiol; 2013 Jan; 111(2):166-71. PubMed ID: 23102877 [TBL] [Abstract][Full Text] [Related]
35. Impact of statin therapy on patients with coronary heart disease and aortic aneurysm or dissection. Tazaki J; Morimoto T; Sakata R; Okabayashi H; Yamazaki F; Nishiwaki N; Mitsudo K; Kimura T; J Vasc Surg; 2014 Sep; 60(3):604-12.e2. PubMed ID: 24797553 [TBL] [Abstract][Full Text] [Related]
36. Two-year outcomes of statin therapy in patients with acute myocardial infarction with or without dyslipidemia after percutaneous coronary intervention in the era of new-generation drug-eluting stents within Korean population: Data from the Korea Acute Myocardial Infarction Registry. Kim YH; Her AY; Jeong MH; Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y Catheter Cardiovasc Interv; 2019 Jun; 93(7):1264-1275. PubMed ID: 30474346 [TBL] [Abstract][Full Text] [Related]
37. Impact of LR11 as Residual Risk on Long-Term Clinical Outcomes in Patients with Coronary Artery Disease Treated with Statins after First Percutaneous Coronary Intervention. Suwa S; Ogita M; Takahashi N; Wada H; Dohi T; Kasai T; Okazaki S; Shimada K; Miyauchi K; Bujo H; Daida H Int Heart J; 2020 May; 61(3):470-475. PubMed ID: 32350212 [TBL] [Abstract][Full Text] [Related]
38. A Propensity Score Matched Analysis of Statin Effects on Major Adverse Cardiac Events after Percutaneous Coronary Intervention in Patients Over 75 Years Old. Horikoshi T; Nakamura T; Yoshizaki T; Nakamura J; Watanabe Y; Uematsu M; Makino A; Saito Y; Obata JE; Sawanobori T; Takano H; Umetani K; Watanabe A; Asakawa T; Sato A; Kugiyama K Intern Med; 2022 Sep; 61(18):2711-2719. PubMed ID: 35228422 [TBL] [Abstract][Full Text] [Related]
39. Association of in-hospital intensive statins dosage and death in arteriosclerotic cardiovascular disease with percutaneous coronary intervention: insights of multicentre cohort from China. Chen PY; Liu YH; Duan CY; Fan HL; Zeng LH; Guo W; Jiang L; Wei XB; He WF; Tao S; Guo ZQ; Chen JY; Tan N; He PC Eur J Clin Pharmacol; 2020 Dec; 76(12):1755-1763. PubMed ID: 32700000 [TBL] [Abstract][Full Text] [Related]
40. Clinical impact of high-sensitivity C-reactive protein during follow-up on long-term adverse clinical outcomes in patients with coronary artery disease treated with percutaneous coronary intervention. Shitara J; Ogita M; Wada H; Tsuboi S; Endo H; Doi S; Konishi H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Suwa S; Miyauchi K; Daida H J Cardiol; 2019 Jan; 73(1):45-50. PubMed ID: 30001869 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]